Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 2710Session 2025-2026

An Act providing for mandatory reporting of babesiosis; requiring continuing education regarding tick-borne disease; imposing duties on the Department of Health and licensing boards; and promulgating regulations.

Printer's No. PN3787

See other bills
under the
same topic PRINTER'S NO. 3787 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2710 Session of 2026 INTRODUCED BY WALLEN, McNEILL, MOUL, SMITH, KUZMA AND KAUFFMAN, JULY 21, 2026 REFERRED TO COMMITTEE ON HEALTH, JULY 22, 2026 AN ACTProviding for mandatory reporting of babesiosis; requiring continuing education regarding tick-borne disease; imposing duties on the Department of Health and licensing boards; and promulgating regulations.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Short title.This act shall be known and may be cited as the Tick-Borne Disease Reporting Act.Section 2. Legislative findings.The General Assembly finds as follows:(1) The rapid increase of tick-borne disease cases within the last decade, as reported by the Department of Health, poses a serious public health issue in this Commonwealth.(2) The most recent data from the United States Centers for Disease Control and Prevention indicates that babesiosis cases increased significantly between 2011 and 2019, particularly in northeastern states. According to 2023 12345678910111213141516171819 Centers for Disease Control and Prevention data, babesiosis is a reportable condition in 40 states, but not in this Commonwealth.(3) The early clinical diagnosis and treatment of tick-borne illnesses can greatly reduce the risks of continued and chronic symptoms that can impair a patient's life.(4) Health care practitioners continuing medical education relating to the diagnosis and treatment of tick-borne diseases is crucial to properly diagnose and treat patients.Section 3. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:"Babesiosis." A tick-transmissible disease whereby a parasite infects red blood cells, primarily, but not always, caused by babesia microti. The term includes an infection that meets the surveillance criteria established by the United States Centers for Disease Control and Prevention."Clinical laboratory." A place, establishment or institution organized and operated primarily for the performance of all or any bacteriological, biochemical, microscopical, serological or parasitological tests by the practical application of one or more of the fundamental sciences to material originating from the human body by the use of specialized apparatus, equipment and methods for the purpose of obtaining scientific data that may be used as an aid to ascertain the state of health."Department." The Department of Health of the Commonwealth."Electronic disease surveillance system." An electronic or web-based platform used by the department to collect and manage 20260HB2710PN3787 - 2 - 123456789101112131415161718192021222324252627282930 information relating to reportable diseases, infections and conditions under the act of April 23, 1956 (1955 P.L.1510, No.500), known as the Disease Prevention and Control Law of 1955, and regulations promulgated under the act. The term includes an electronic laboratory reporting system."Electronic laboratory reporting system." The electronic platform that the department uses to receive and process information electronically generated by clinical laboratories and to route the information to the department's electronic disease surveillance system when appropriate."Health care facility."(1) A health care facility includes:(i) A general, chronic disease or other type of hospital.(ii) A home health care agency.(iii) A home care agency.(iv) A hospice.(v) A long-term care nursing facility.(vi) A cancer treatment center that uses radiation therapy on an ambulatory basis.(vii) An ambulatory surgical facility.(viii) A birth center regardless of whether the birth center is operated for profit, nonprofit or by an agency of the Commonwealth or local government.(2) The term shall not include:(i) An office used primarily for the private practice of a health care practitioner.(ii) A program which renders treatment or care for drug or alcohol abuse or dependence unless located within a health facility.20260HB2710PN3787 - 3 - 123456789101112131415161718192021222324252627282930 (iii) A facility providing treatment solely on the basis of prayer or spiritual means.(iv) A facility conducted by a religious organization for the purpose of providing a health care service exclusively to clergymen or other person in a religious profession who are members of a religious denomination."Health care practitioner." An individual who is authorized to practice some component of the healing arts by a license, permit, certificate or registration issued by a licensing agency or board of this Commonwealth."Licensing board." A licensing board under the Bureau of Professional and Occupational Affairs in the Department of State with jurisdiction over professional licensees or certificate holders who are health care practitioners."Tick-borne disease." A disease transmitted by a tick with signs or symptoms consistent with infection with Lyme disease, babesiosis, bartonella, anaplasmosis, ehrlichiosis, hard tick relapsing fever, Rocky Mountain spotted fever, rickettsiosis, Powassan or other tick-transmissible illness or complications related to an infection from a tick.Section 4. Reporting of babesiosis.(a) Health care practitioner or facility.--After being identified by symptoms, appearance or diagnosis, a health care practitioner or health care facility that treats or examines a case of babesiosis shall report the case through the electronic disease surveillance system.(b) Clinical laboratories.--A person in charge of a clinical laboratory shall report a positive specimen test of babesiosis through the electronic laboratory reporting system.20260HB2710PN3787 - 4 - 123456789101112131415161718192021222324252627282930 (c) Timing of reporting.--Reports shall be made no later than five work days to the electronic disease surveillance system.(d) Notification.--The department shall publicly notify health care practitioners, health care facilities and clinical laboratories of this act and temporarily provide a reporting timeline until regulations are promulgated under this act.(e) Penalties.--(1) If a health care practitioner fails to file a report under this section, the department may refer the matter to the appropriate licensure board for disciplinary action.(2) If a health care facility licensed by the department fails to file a report under this section, the department may place restrictions on or revoke the health care facility's license, as provided for in the act of July 19, 1979 (P.L.130, No.48), known as the Health Care Facilities Act.(3) If a clinical laboratory fails to file a report under this section, the department may place restrictions on or revoke the laboratory's permit to operate as a clinical laboratory, as provided for in the act of September 26, 1951 (P.L.1539, No.389), known as The Clinical Laboratory Act. If the failure to report is due to circumstances beyond the control of the clinical laboratory, the department may not impose a penalty.Section 5. Continuing education requirement in tick-borne disease.(a) Licensing boards.--A licensing board shall require a health care practitioner applying for a renewal of a license or certification to complete at least one hour of continuing medical education approved by the licensing board in the 20260HB2710PN3787 - 5 - 123456789101112131415161718192021222324252627282930 diagnosis and treatment of tick-borne diseases as part of, but not in addition to, hours required for license renewal.(b) Consultation with department.--A licensing board shall, in consultation with the department, approve the curricula for continuing education relating to the diagnosis and treatment of tick-borne diseases.(c) Content.--The courses shall represent an appropriate spectrum of the most current, evidence-based research relating to medical clinical diagnosis and treatment relating to tick-borne disease in this Commonwealth.Section 6. Regulations.(a) Department.--The department shall adopt rules and promulgate and enforce regulations consistent with this act.(b) Licensing boards.--No later than 24 months after the effective date of this subsection, a licensing board shall promulgate final regulations necessary to implement this act.Section 7. Effective date.This act shall take effect immediately.20260HB2710PN3787 - 6 - 123456789101112131415161718

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.